Mary Beth Fritz sold $810k of PBH
SVP Quality & Regulatory at Prestige Consumer Healthcare Inc.. 9,885 shares at an average of $81.97, traded Nov 12, 2024, filed Nov 14, 2024.
Score components
- +15RoleOfficer
- +22Trade size$810k at market
- +10Share of holdings soldSold 39% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -0.6%, 3m +3.5%, 6m +5.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-119386, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 12, 2024 | AGrant or award Common Stock, par value $0.01 per share | +6,471 | $39.98 | $259k | 25,306 | Nov 14, 2024 |
| Nov 12, 2024 | SOpen-market sale Common Stock, par value $0.01 per share | -6,471 | $81.99 | $531k | 18,835 | Nov 14, 2024 |
| Nov 12, 2024 | AGrant or award Common Stock, par value $0.01 per share | +3,414 | $54.47 | $186k | 22,249 | Nov 14, 2024 |
| Nov 12, 2024 | SOpen-market sale Common Stock, par value $0.01 per share | -3,414 | $81.93 | $280k | 18,835 | Nov 14, 2024 |
| Nov 12, 2024 | MOption exercise Employee Stock Options (right to buy)derivative | -6,471 | $0.00 | $0 | 0 | Nov 14, 2024 |
| Nov 12, 2024 | MOption exercise Employee Stock Options (right to buy)derivative | -3,414 | $0.00 | $0 | 1,708 | Nov 14, 2024 |
Related signals
Other insiders at Prestige Consumer Healthcare Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Prestige Consumer Healthcare Inc. | Jeffrey Zerillo Senior VP Operations | $18k 351 shares | -1% | |
| 0Weak | Prestige Consumer Healthcare Inc. | Jeffrey Zerillo Senior VP Operations | $17k 305 shares | -1% | |
| 23Weak | PBHsell Prestige Consumer Healthcare Inc. | Jeffrey Zerillo Senior VP Operations | $66k 1,207 shares | -3% | |
| 0Weak | Prestige Consumer Healthcare Inc. | Jeffrey Zerillo Senior VP Operations | $19k 346 shares | -1% | |
| 23Weak | PBHsell Prestige Consumer Healthcare Inc. | Jeffrey Zerillo Senior VP Operations | $66k 1,000 shares | -2% | |
| 10Weak | Prestige Consumer Healthcare Inc. | Jeffrey Zerillo Senior VP Operations | $60k 1,000 shares | -2% | |
| 35Weak | Prestige Consumer Healthcare Inc. | John E Byom director | $178k 3,000 shares | -5% | |
| 6Weak | Prestige Consumer Healthcare Inc. | Mary Beth Fritz SVP Quality & Regulatory | $151k 1,678 shares | -9% | |
| 9Weak | Prestige Consumer Healthcare Inc. | Mary Beth Fritz SVP Quality & Regulatory | $538k 6,297 shares | -25% | |
| 49Moderate | Prestige Consumer Healthcare Inc. | Ronald M. Lombardi Chief Executive Officer | $898k 10,875 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.